ANI Pharmaceuticals CEO presents at investor conference; no financial results disclosed in filing

ANI PHARMACEUTICALS INC

President & CEO Nikhil Lalwani participated in Capital One Securities Biotech/Biopharma Disruptors Event on May 14, 2024.
Investor presentation attached as Exhibit 99.1 was referenced but not included in the provided text.
No new financial or operational data, guidance changes, or material events can be extracted from the filing alone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.